PortfoliosLab logo
Vicarious Surgical Inc. (RBOT)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US92561V1098

CUSIP

92561V109

IPO Date

Sep 4, 2020

Highlights

Market Cap

$49.06M

EPS (TTM)

-$10.74

Total Revenue (TTM)

$2.09M

Gross Profit (TTM)

$521.00K

EBITDA (TTM)

-$44.65M

Year Range

$4.27 - $19.00

Target Price

$10.75

Short %

3.58%

Short Ratio

5.89

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Vicarious Surgical Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%December2025FebruaryMarchAprilMay
-96.98%
65.28%
RBOT (Vicarious Surgical Inc.)
Benchmark (^GSPC)

Returns By Period

Vicarious Surgical Inc. (RBOT) returned -32.83% year-to-date (YTD) and -2.53% over the past 12 months.


RBOT

YTD

-32.83%

1M

74.02%

6M

10.92%

1Y

-2.53%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.70%

1M

13.67%

6M

-5.18%

1Y

9.18%

5Y*

14.14%

10Y*

10.43%

*Annualized

Monthly Returns

The table below presents the monthly returns of RBOT, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20251.37%-17.54%-40.36%25.91%7.02%-32.83%
20249.74%5.47%-28.96%-6.93%12.30%-37.90%22.49%-12.24%-9.98%39.26%76.86%-5.93%19.63%
202334.16%3.32%-18.93%-0.88%-6.67%-12.86%-10.38%-43.62%-36.11%-30.17%-33.41%33.49%-81.85%
2022-39.45%-4.04%-17.99%-2.77%-10.98%-32.88%32.65%-4.36%-10.19%15.52%-9.56%-42.29%-80.98%
2021-0.00%0.89%-3.02%-0.10%-0.40%0.81%-0.50%0.60%49.90%-12.63%0.23%-18.93%4.53%
20200.21%-1.13%1.66%3.46%4.21%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of RBOT is 55, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of RBOT is 5555
Overall Rank
The Sharpe Ratio Rank of RBOT is 5151
Sharpe Ratio Rank
The Sortino Ratio Rank of RBOT is 6565
Sortino Ratio Rank
The Omega Ratio Rank of RBOT is 6161
Omega Ratio Rank
The Calmar Ratio Rank of RBOT is 5050
Calmar Ratio Rank
The Martin Ratio Rank of RBOT is 5050
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Vicarious Surgical Inc. (RBOT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The current Vicarious Surgical Inc. Sharpe ratio is -0.02. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Vicarious Surgical Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00December2025FebruaryMarchAprilMay
-0.02
0.48
RBOT (Vicarious Surgical Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Vicarious Surgical Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-98.03%
-7.82%
RBOT (Vicarious Surgical Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Vicarious Surgical Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Vicarious Surgical Inc. was 98.87%, occurring on Apr 8, 2025. The portfolio has not yet recovered.

The current Vicarious Surgical Inc. drawdown is 98.03%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.87%Oct 1, 2021883Apr 8, 2025
-9.5%Feb 22, 2021144Sep 15, 20211Sep 16, 2021145
-7.84%Sep 27, 20212Sep 28, 20212Sep 30, 20214
-4.54%Sep 22, 20212Sep 23, 20211Sep 24, 20213
-2.53%Oct 5, 20205Oct 9, 202044Dec 11, 202049

Volatility

Volatility Chart

The current Vicarious Surgical Inc. volatility is 35.00%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%December2025FebruaryMarchAprilMay
35.00%
11.21%
RBOT (Vicarious Surgical Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Vicarious Surgical Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Vicarious Surgical Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 9.7% positive surprise.


-3.00-2.50-2.00-1.50-1.00-0.500.00October2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
-2.43
-2.69
Actual
Estimate

Valuation

The Valuation section provides an overview of how Vicarious Surgical Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for RBOT relative to other companies in the Medical Devices industry. Currently, RBOT has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for RBOT in comparison with other companies in the Medical Devices industry. Currently, RBOT has a P/B value of 1.1. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items